Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm
- PMID: 26344852
- DOI: 10.1016/j.jep.2015.08.052
Cancer patients taking herbal medicines: A review of clinical purposes, associated factors, and perceptions of benefit or harm
Abstract
Ethnopharmacological relevance: Cancer patients in all cultures are high consumers of herbal medicines (HMs) usually as part of a regime consisting of several complementary and alternative medicine (CAM) modalities, but the type of patient, the reasons for choosing such HM-CAM regimes, and the benefits they perceive from taking them are poorly understood. There are also concerns that local information may be ignored due to language issues. This study investigates aspects of HM-CAM use in cancer patients using two different abstracting sources: Medline, which contains only peer-reviewed studies from SCI journals, and in order to explore whether further data may be available regionally, the Thai national databases of HM and CAM were searched as an example.
Materials and methods: The international and Thai language databases were searched separately to identify relevant studies, using key words chosen to include HM use in all traditions. Analysis of these was undertaken to identify socio-demographic and clinical factors, as well as sources of information, which may inform the decision to use HMs.
Results: Medline yielded 5638 records, with 49 papers fitting the criteria for review. The Thai databases yielded 155, with none relevant for review. Factors associated with HM-CAM usage were: a younger age, higher education or economic status, multiple chemotherapy treatment, late stage of disease. The most common purposes for using HM-CAM cited by patients were to improve physical symptoms, support emotional health, stimulate the immune system, improve quality of life, and relieve side-effects of conventional treatment.
Conclusions: Several indicators were identified for cancer patients who are most likely to take HM-CAM. However, interpreting the clinical reasons why patients decide to use HM-CAM is hampered by a lack of standard terminology and thematic coding, because patients' own descriptions are too variable and overlapping for meaningful comparison. Nevertheless, fears that the results of local studies published regionally are being missed, at least in the case of Thailand, appeared to be unfounded.
Keywords: Cancer patient; Complementary and alternative medicine; Food supplement; Herbal medicine; Review.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Complementary and alternative medicine use among cancer patients in Palestine with special reference to safety-related concerns.J Ethnopharmacol. 2016 Jul 1;187:104-22. doi: 10.1016/j.jep.2016.04.038. Epub 2016 Apr 25. J Ethnopharmacol. 2016. PMID: 27125594
-
Usage of and cost of complementary/alternative medicine in diabetic patients.J Med Assoc Thai. 2005 Nov;88(11):1630-7. J Med Assoc Thai. 2005. PMID: 16471112
-
Use of complementary and alternative medicine by chinese women with breast cancer.Breast Cancer Res Treat. 2004 Jun;85(3):263-70. doi: 10.1023/B:BREA.0000025422.26148.8d. Breast Cancer Res Treat. 2004. PMID: 15111765
-
Herbal Medicines: challenges in the modern world. Part 5. status and current directions of complementary and alternative herbal medicine worldwide.Expert Rev Clin Pharmacol. 2017 Mar;10(3):327-338. doi: 10.1080/17512433.2017.1268917. Epub 2016 Dec 15. Expert Rev Clin Pharmacol. 2017. PMID: 27923318 Review.
-
Why do some cancer patients receiving chemotherapy choose to take complementary and alternative medicines and what are the risks?Asia Pac J Clin Oncol. 2014 Mar;10(1):1-10. doi: 10.1111/ajco.12115. Epub 2013 Aug 5. Asia Pac J Clin Oncol. 2014. PMID: 23910177 Review.
Cited by
-
Immunoregulation of Shenqi Fuzheng Injection Combined with Chemotherapy in Cancer Patients: A Systematic Review and Meta-Analysis.Evid Based Complement Alternat Med. 2017;2017:5121538. doi: 10.1155/2017/5121538. Epub 2017 Jan 5. Evid Based Complement Alternat Med. 2017. PMID: 28154607 Free PMC article. Review.
-
Coping behavior in multiple sclerosis-complementary and alternative medicine: A cross-sectional study.CNS Neurosci Ther. 2018 Sep;24(9):784-789. doi: 10.1111/cns.12857. Epub 2018 Apr 10. CNS Neurosci Ther. 2018. PMID: 29635832 Free PMC article.
-
Predictors of herbal medicine use among cancer patients.J Cancer Res Clin Oncol. 2023 Jul;149(8):4991-5005. doi: 10.1007/s00432-022-04451-x. Epub 2022 Nov 1. J Cancer Res Clin Oncol. 2023. PMID: 36318333 Free PMC article.
-
Green Extraction of Plant Materials Using Supercritical CO2: Insights into Methods, Analysis, and Bioactivity.Plants (Basel). 2024 Aug 18;13(16):2295. doi: 10.3390/plants13162295. Plants (Basel). 2024. PMID: 39204731 Free PMC article. Review.
-
Identifying Drug Interactions between Enzalutamide and Complementary Alternative Medications in a Patient with Metastatic Prostate Cancer: A Case Report.Can J Hosp Pharm. 2018 Jul-Aug;71(4):276-281. Epub 2018 Aug 28. Can J Hosp Pharm. 2018. PMID: 30186002 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical